ROCKVILLE, Md. — The American Society of Human Genetics (ASHG), the world’s preeminent professional organization dedicated to the field of human genetics and genomics, has officially announced the seven recipients of its prestigious 2026 Professional Awards. These honors, which recognize a diverse array of accomplishments in research, education, mentorship, and public advocacy, highlight the pivotal role that genetic science plays in the modern era of medicine and human health.
The 2026 cohort represents the highest echelon of the scientific community, spanning pioneers who laid the groundwork for the Human Genome Project to early-career investigators who are currently redefining the boundaries of precision medicine. The awards will be formally presented during the ASHG 2026 Annual Meeting, scheduled for October 20–24 in Montréal, a global gathering that serves as the cornerstone for progress in genetic discovery.
The 2026 Laureates: A Legacy of Innovation
The ASHG awards reflect a commitment to honoring both the long-standing titans of the field and the emerging voices that are shaping the next decade of discovery.
ASHG Lifetime Achievement Award: Dr. Yusuke Nakamura
Dr. Yusuke Nakamura, President of the National Institutes of Biomedical Innovation, Health and Nutrition in Japan, has been honored for a career defined by profound, far-reaching contributions. From his early work in pioneering polymorphic Variable Number Tandem Repeat (VNTR) markers—which provided the foundation for the era of positional cloning—to his leadership in the International HapMap Project, Dr. Nakamura has fundamentally altered the landscape of genomic research. His work on the APC gene and colorectal cancer, coupled with the establishment of BioBank Japan, has served as a bedrock for modern precision medicine and oncology.
ASHG Leadership Award: Dr. Aravinda Chakravarti
As the Director of the Center for Human Genetics and Genomics at NYU Grossman School of Medicine, Dr. Aravinda Chakravarti is recognized for his singular role in integrating genetics into the broader scientific fabric. His career includes foundational work in population genetics and linkage disequilibrium mapping, as well as critical contributions to the Human Genome Project and the 1000 Genomes Project. Dr. Chakravarti’s influence extends beyond the lab; as a former ASHG president and editor, he has fostered the collaborative infrastructure that defines today’s global genetic research enterprise.
ASHG Scientific Achievement Award: Dr. Wendy Chung
Dr. Wendy Chung, Chief of Pediatrics at Boston Children’s Hospital and Professor at Harvard Medical School, has been honored for her transformative research over the past decade. Her work is marked by an extraordinary breadth, encompassing congenital anomalies, neurodevelopmental disorders, and rare Mendelian conditions. Dr. Chung’s commitment to translating bench science to the bedside has led to the identification of over 60 disease-associated genes, directly influencing newborn sequencing and population-based screening strategies.
ASHG Early Career Award: Dr. Rebecca Ahrens-Nicklas
The future of genomic medicine is currently being written by researchers like Dr. Rebecca Ahrens-Nicklas, an Associate Professor at the Children’s Hospital of Philadelphia. Dr. Ahrens-Nicklas has been recognized for her pioneering efforts in developing the world’s first personalized in vivo CRISPR therapy for an infant with an ultra-rare metabolic disease. Her work represents a new paradigm in "N-of-1" precision medicine, where genetic diagnosis is immediately paired with a custom therapeutic path.
ASHG Advocacy Award: Roxanne Khamsi
Bridging the gap between the laboratory and the public, science journalist Roxanne Khamsi is being recognized for her two decades of reporting on the intersection of genetics and human experience. Her contributions to outlets like The Atlantic and WIRED have provided the public with a nuanced understanding of genetic disease, while her recent book, Beyond Inheritance, challenges reductive, deterministic views of genetic mutations.
ASHG Education Award: Dr. Robbee Wedow
Dr. Robbee Wedow, Assistant Professor at Purdue University, has been honored for his transformative work in genetic pedagogy. As a co-investigator of the Humane Genetics Curriculum (HGC), Dr. Wedow has revolutionized how students engage with complex topics like ancestry, race, and genetic variation. His teaching model provides a framework for students in medicine, law, and public policy to approach genetic data with both rigorous scientific understanding and social responsibility.
ASHG Mentorship Award: Dr. Nancy B. Spinner
Recognized for a 35-year commitment to nurturing the next generation of scientists, Dr. Nancy B. Spinner, currently Associate Chair of Genomic Strategy at Northwell Health, is celebrated for her exceptional record of mentorship. Having trained more than 23 laboratory directors—many of whom now hold prominent faculty positions—Dr. Spinner has fostered a culture of inclusivity and professional development that remains a benchmark for the field.
Chronology of Scientific Impact
The trajectory of these awardees mirrors the evolution of the field of genetics itself. In the 1980s and 90s, the field was focused on discovery: mapping the genome, identifying individual disease genes, and developing the tools necessary to read the genetic code. Figures like Dr. Nakamura and Dr. Chakravarti were instrumental in these foundational years.
By the early 2000s, the focus shifted toward large-scale collaborative projects, such as the HapMap Project, which allowed researchers to understand common genetic variation. As these tools matured, the field moved into the "translational" era of the 2010s, where leaders like Dr. Wendy Chung began integrating high-throughput genomic data into clinical care to diagnose previously mysterious conditions.
Today, in 2026, the focus has shifted toward precision therapies and education. Researchers like Dr. Ahrens-Nicklas are utilizing CRISPR and other gene-editing technologies to treat the very conditions discovered in the previous decades, while educators like Dr. Wedow are ensuring that the societal implications of this power are understood by the next generation.
Supporting Data: The Power of Genetics in Modern Society
The accomplishments of these honorees are not merely academic; they translate into tangible improvements in human health. The data surrounding their collective impact is significant:
- Gene Discovery: Over 60 genes identified by Dr. Chung’s team have provided answers to families previously trapped in "diagnostic odysseys."
- Clinical Implementation: The shift toward population-based screening, championed by several awardees, has resulted in earlier interventions for preventable conditions, significantly reducing morbidity.
- Precision Therapy: The work of Dr. Ahrens-Nicklas suggests a future where orphan diseases—once thought to be untreatable—can be addressed through highly individualized, genomic-based interventions.
- Public Understanding: Through the work of advocates like Roxanne Khamsi and educators like Dr. Wedow, the scientific community is effectively combating misinformation, ensuring that public policy regarding genetics is grounded in accurate data rather than outdated biological concepts.
Official Perspectives: The Future of the Field
In reflecting on this year’s cohort, Dr. Susan A. Slaugenhaupt, President of the ASHG, underscored the vital importance of these awards.
"ASHG is honored to recognize this exceptional group of awardees, whose work demonstrates the many ways human genetics and genomics can advance science and serve society," Dr. Slaugenhaupt stated. "Each honoree has helped shape a stronger, more collaborative, and more impactful field. Their achievements inspire our community and reflect the promise of genetics to improve lives around the world."
The sentiment is echoed by the broader scientific community, which views these awards as a reflection of the field’s current health. As genomic data becomes more accessible, the challenges shift from data acquisition to data interpretation and ethical application. The 2026 awardees, through their diverse roles, exemplify the multidisciplinary approach required to solve these modern challenges.
Implications for the Future of Healthcare
The recognition of these seven individuals carries profound implications for the direction of medical science.
- Democratization of Knowledge: Through the efforts of educators and journalists, the "black box" of genetics is being opened to the public, fostering informed consent and better patient advocacy.
- Shift toward Individualization: The transition from "one-size-fits-all" medicine to bespoke, gene-based therapy is accelerating. The work of this year’s awardees highlights the transition from identifying "what" a gene does to "how" we can modify it for therapeutic benefit.
- Global Collaboration: The inclusion of international leaders like Dr. Nakamura underscores that genetics is a global endeavor. The future of the field depends on the continued integration of BioBanks, international datasets, and shared ethical standards.
- Mentorship as a Metric of Success: By honoring Dr. Spinner, the ASHG signals that the long-term sustainability of the field relies on the quality of mentorship. As the complexity of genomics grows, the need for well-trained, ethically grounded scientists becomes more urgent.
As the ASHG prepares for its annual meeting in Montréal this October, the scientific community will gather not only to celebrate these seven individuals but to build upon the foundations they have laid. The 2026 awards stand as a testament to the fact that when scientific rigor is combined with human compassion and visionary leadership, the possibilities for human health are limitless.
For those interested in witnessing the future of the field, press registration for the ASHG 2026 Annual Meeting is currently open at ashgmeeting.ashg.org.
About the Author
